Crimson Life Sciences

Crimson Life Sciences, a division of TransPerfect, is a leading provider of language and regulatory services specifically tailored for the medical device and biotechnology sectors. The company is recognized for being the first translation organization to achieve ISO 13485 and ISO 14971 certifications, underscoring its commitment to the rigorous quality and risk management standards required in life sciences. Crimson specializes in the translation of clinical trial documentation, regulatory submissions, and product labeling, helping manufacturers navigate the complexities of global market entry. Their expertise extends to providing strategic consulting for compliance with international regulations such as the EU MDR and IVDR. By leveraging proprietary technology and a global network of subject-matter experts, Crimson ensures that technical content is both linguistically accurate and regulatory-compliant.